[Hemostatic disturbances in obesity]
Renata Swiatkowska-Stodulska1, Ewa Kazimierska, Krzysztof Sworczak
1Kliniki Chorób Wewnetrznych, Endokrynologii i Zaburzeń Hemostazy Instytutu Chorób Wewnetrznych Akademii Medycznej w Gdańsku.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|August 31, 2007
Summary
Obesity significantly increases the risk of blood clots by disrupting coagulation and impairing fibrinolysis. This study investigates these hemostasis disorders in obese individuals.
Area of Science:
- Cardiovascular Science
- Hematology
- Endocrinology
Context:
- Obesity is a chronic disease linked to increased thromboembolic events affecting both arterial and venous systems.
- Hemostasis disorders, including hypercoagulability and impaired fibrinolysis, are implicated in the development of these events in obese individuals.
Purpose:
- To investigate the complex coagulation and fibrinolysis disorders in obese individuals.
- To explore the influence of hormonal, metabolic, and endothelial changes, as well as adipocytokines, on hemostasis mechanisms in obesity.
Summary:
- Obesity is associated with elevated levels and activity of clotting factors, hyperfibrinogenemia, and platelet hyperactivity.
- Obese individuals exhibit impaired fibrinolysis, contributing to a prothrombotic state.
- Hormonal, metabolic, endothelial, and adipocytokine factors play a role in obesity-related hemostasis dysregulation.
Impact:
- Understanding these hemostasis alterations is crucial for managing thromboembolic risk in obesity.
- This research provides insights into the mechanisms underlying obesity-associated thrombophilia.
- Findings may inform targeted therapeutic strategies for preventing clot formation in obese patients.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...